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Objectives The aim of this study was to assess the validity of measuring fractional ﬂow reserve
(FFR) of the left main (LM) coronary artery in the setting of concomitant left anterior descending
(LAD) or left circumﬂex (LCX) stenoses.
Background The theoretical impact of a stenosis in the LAD on the FFR assessment of intermediate
LM disease with the pressure wire in an unobstructed LCX is currently unknown.
Methods A previously validated in vitro model of the coronary circulation was used to create a
ﬁxed intermediate stenosis of the LM and a variable downstream LAD or LCX stenosis. The true LM
FFR (FFRLM true), with no concomitant downstream disease, was compared to the apparent LM
FFR (FFRLM apparent), with concomitant downstream disease measured with different degrees of LAD
or LCX disease. Additionally, an equation based on a resistors model was derived to predict the ef-
fect of downstream stenosis on LM FFR (FFRLM predicted).
Results In the setting of isolated moderate LM disease (FFR 0.72  0.08), mild to moderate proxi-
mal LAD or LCX lesions did not signiﬁcantly affect LM FFR. Lesions with a composite FFR (LM 
downstream disease) 0.65 resulted in an FFRLM apparent that was not signiﬁcantly different
rom FFRLM true (0.76  0.06 vs. 0.76  0.05, p  0.124). Our equation for FFRLM predicted accu-
rately modeled the effects of concomitant disease (r  0.95, p  0.001).
onclusions These data suggest that in the presence of proximal mild to moderate LAD or LCX
isease, LM FFR can be reliably measured with the pressure wire placed in the uninvolved epicardial
rtery. (J Am Coll Cardiol Intv 2012;5:1021–5) © 2012 by the American College of Cardiology
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1022Multiple studies have highlighted the limitations of the
angiographic assessment of intermediate left main (LM)
coronary artery disease (1). Fractional flow reserve (FFR) is
a well-accepted invasive technique for determining the
functional significance of epicardial coronary artery disease
(2–4). Although a number of reports have demonstrated the
usefulness of measuring FFR to assess intermediate LM
See page 1026
disease, the effect of downstream epicardial disease in the left
anterior descending artery (LAD) on the FFR assessment of the
LM remains unclear (5,6). Disease in the LAD will certainly affect
FFR assessment of the LM when
the pressure wire is in the distal
LAD. However, in theory, LAD
disease might also affect the FFR
assessment of the LM when the
pressure wire is positioned in a non-
diseased left circumflex artery
(LCX). The flow across the LM
depends on the outflow to the
LAD and LCX, and therefore the
LAD stenosis impairs maximal
flow across the LM, which will
falsely elevate the FFR.
The goal of this study is to
explore the effect of increasingly
severe downstream disease in ei-
ther the LAD or the LCX on
FFR assessment of intermediate
LM disease when the pressure
wire is positioned in the nondis-
eased epicardial vessel.
Methods
Procedure. A previously validated
in vitro model of the coronary cir-
culation was used to simulate the
LM with a distal bifurcation into
he 2 daughter vessels representing the LAD and LCX (Fig. 1)
7). This model simulates pulsatile cardiovascular flow using a
iston pump in conjunction with mechanical mitral and aortic
alves. The microvascular resistance in the distal LAD and LCX
an be independently adjusted to tune the model to approximate
oth appropriate volume of flow for those perfusion territories, as
ell as flow velocity characteristics approximating human coro-
ary flow (typically 400 ml/min for the LAD). A mechanical
ccluder was attached to the LM to create a variable stenosis.
erivascular flow probes (Transonic Systems Inc., Ithaca, New
ork) were fitted onto each branch vessel along with mechanical
Abbreviations
and Acronyms
FFR  fractional flow
reserve
FFRLM apparent  left main
FR in the setting of a
oncomitant left anterior
escending or left circumflex
tenosis
FRLM predicted  predicted
true fractional flow reserve
of the left main stenosis in
the setting of concomitant
left anterior descending or
left circumflex stenosis
FFRLM true  true fractional
ow reserve of left main
tenosis
AD  left anterior
descending coronary artery
LCX  left circumflex
coronary artery
LM  left main coronary
artery
Pa  mean aortic pressure
d LAD  mean distal left
nterior descending artery
ressure beyond all stenoses
d LCX  mean distal left
ircumflex artery pressure
eyond all stenosesccluders distal to each probe. A fluid-filled pressure transducer Las attached to the proximal aorta to measure mean aortic
ressure (Pa). A pressure wire (St. Jude Medical, St. Paul,
Minnesota) was advanced distally to each daughter vessel to
measure distal LAD pressure (Pd LAD) and distal LCX pressure
(P
d LCX
). Absolute flow in the LAD and LCX was measured at
each step using a flow meter (Transonic Systems Inc.) These data
were simultaneously acquired with an analog-to-digital converter
and a custom LabVIEW application (National Instruments,
Austin, Texas) sample rate of 1,000 Hz. To account for difference
in distal myocardial perfusion territory and flow between the
LAD and LCX, the model was tuned to approximate human
physiological conditions during maximal coronary hyperemia
with a LAD/LCX flow of 2:1. An isolated moderate LM
stenosis was created and PdLCX/Pa was termed true FFR of the
LM (FFRLM true). A progressive LAD stenosis was created
from mild to severe and the apparent FFR value of the LM
(FFR
LM apparent
) was also calculated as PdLCX/Pa (but in the presence
of a stenosis in the LAD). The same was repeated with a
concomitant stenosis in the LCX and FFRLM apparent was in this
case calculated as PdLAD/Pa. We define “composite FFR” as the
LM lesion plus the downstream lesion with the pressure wire
distal to both lesions. Mild to moderate LAD/LCX lesions were
arbitrarily defined as a composite FFR of0.65 and severe lesions
as 0.65.
Prediction of LM FFR. The severity of the true FFR value of
he LM is underestimated in the presence of concomitant
oronary artery disease. Therefore, an equation to predict
he FFR value of the LM (FFRLM predicted) was developed
ased on a resistance model of the coronary circulation.
hese equations were applied to predict the true FFR of the
M (Online Appendix). FFR values of 0.15 were ex-
luded since these values are not physiological.
Statistics. FFRLM true was compared with FFRLM apparent
and FFRLM predicted using paired t tests. Linear correlation
as performed with FFRLM apparent versus FFRLM true, and
FFRLM predicted versus FFRLM true. The Pearson correlation
was calculated and a Z test was applied to assess for
ifferences between dependent correlations (8).
A plot was constructed to assess the accuracy of the predictive
quation across the range of distal stenosis severity. A 2-sided p
alue 0.05 was considered statistically significant.
esults
FFR was measured in LM lesions with progressive LAD or
LCX stenoses (n  75). FFRLM true was 0.72  0.08 and
anged from 0.57 to 0.82. FFRLM apparent had a moderate
orrelation with FFRLM true (r  0.73, p  0.001). The
ivergence of FFRLM apparent from FFRLM true was minimal
for mild to moderate LAD or LCX disease and became
significant only for severe disease (Fig. 2). FFRLM apparent
was significantly higher than FFRLM true (0.78  0.08 vs.
.72  0.08, p  0.001) in the entire cohort (Fig. 3A).
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1023or LCX disease) 0.65 resulted in an FFRLM apparent that
was not significantly different from FFRLM true (0.76 0.06
s. 0.76  0.05, p  0.124) (Fig. 3B) and lesions with a
omposite FFR 0.65 resulted in a higher FFRLM apparent
than FFRLM true (0.79  0.09 vs. 0.70  0.08, p  0.001)
Fig. 3C). LCX disease appeared to have less impact than
AD disease did on the FFR assessment of intermediate
M disease with the pressure wire in the nondiseased
picardial vessel (0.77 0.09 vs. 0.69 0.09, p 0.001 for
FRLM apparent vs. FFRLM true with LAD disease and 0.78 
.07 vs. 0.73  0.06, p  0.001 for FFRLM apparent
vs. FFRLM true with LCX disease) (Figs. 4A and 4B).
Using the equation for FFRLM predicted, the correlation with
FFRLM true was much stronger (r 0.95, p 0.001). The linear
regression equation for FFRLM predicted versus FFRLM true was
 1.02x  0.01, indicating the prediction model not only
orrelated with FFRLM true, but was physiologically sound as
the regression approximated the line of identity. Our equation
for FFRLM predicted was accurate through the range of down-
stream disease from mild to severe (Fig. 5). The correlation
with FFRLM true was significantly stronger for FFRLM predicted
in comparison with FFRLM apparent, z  8.26, p  0.01.
iscussion
In patients with intermediate LM coronary artery disease,
Figure 1. In Vitro Model of the Coronary Circulation
An in vitro model of the coronary circulation with a left main artery (LM)
that bifurcates into the left anterior descending (LAD) and left circumﬂex
(LCX) branches with independently adjustable microcirculatory resistance.
There are variable resistance constrictors around the LM and LAD.accurate determination of functional significance is critical.Isolated LM disease is rare, occurring in 10% of cases (9).
Therefore, a better understanding of the utility and poten-
tial limitations of FFR in the setting of moderate LM
disease with concomitant downstream stenoses is critical to
revascularization decision making. The primary finding of
our study was that in the setting of moderate LM plus
concomitant mild to moderate LAD disease, assessment of
LM FFR with the pressure sensor placed in the LCX artery
is reliable. We found that in the setting of LM plus
downstream disease, the assessment of FFR LM with the
pressure sensor in the nondiseased vessel is not significantly
affected until the composite of the LM and downstream
disease with the pressure sensor in the distal diseased
epicardial vessel is severe (FFR 0.65).
LM plus LCX disease would be expected to affect LM FFR
to a lesser extent than the reverse situation with LM plus LAD
disease because the LCX receives less outflow than the LAD.
Indeed, in our in vitro model, we found this trend as the model
was tuned to approximate human LAD and LCX perfusion
territories with a 2:1 flow ratio. This suggests that LCX lesions
are even less likely to affect LM FFR when measured with the
pressure wire in an unobstructed LAD.
A second major finding was that applying our equation
based on a resistors model accounted for the effect of
downstream disease and allowed for more accurate assess-
ment of LM FFR. FFR can be defined based on flow, as
traditionally calculated, by the ratio of pressure, as used in
clinical practice, or as microcirculatory and epicardial resis-
tances (Online Appendix). By calculating FFR using resis-
tance, we can “virtually” remove an LAD or LCX stenosis to
estimate the isolated LM FFR.
Figure 2. Effect of Downstream Stenosis on LM FFR
Plot of true FFR of LM stenosis (FFRLM true) minus LM FFR in the setting of a con-
comitant LAD or LCX stenosis (FFRLM apparent) on the y-axis as a function of down-
stream stenosis severity (composite LM  LAD or LCX FFR) on the x-axis. Dashed
lines represent 95% conﬁdence intervals. For a ﬁxed LM stenosis, as the down-
stream stenosis becomes more severe, FFRLM apparent rises. An epicardial lesion
with a downstream FFR of 0.60 is associated with a 0.05 overestimation of
FFR
LM true
. Abbreviations as in Figure 1.
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1024We demonstrated that an LM stenosis with concomitant
LAD or LCX disease represents a special case of serial lesions,
Figure 3. Impact of Epicardial Stenosis Severity on Assessment of LM FFR
(A) FFR difference between FFRLM apparent and FFRLM true for the entire cohort.
(B) Difference between FFRLM apparent and FFRLM true for epicardial lesions with
an FFR 0.65. (C) Difference between FFRLM apparent and FFRLM true for epicar-
dial lesions with an FFR 0.65. Abbreviations as in Figure 2.as there is a major side branch and requires a different modelthan that previously described by De Bruyne et al. (10). When
applied to our dataset, these previously described equa-
tions for serial lesions, though an improvement over
FFR
LM apparent
, did not correlate as well with FFRLM true as
the new equation for FFRLM predicted did (r  0.87 vs.
r  0.95). In contrast to serial lesions without a major side
branch in which even mild distal disease significantly affects
the apparent FFR of a proximal lesion, in our model, LM
FFR is not affected by mild to moderate LAD disease and
is falsely elevated only in the presence of a severe proximal
LAD lesion. Accordingly, our model may also be important
when considering serial lesions within a major epicardial
artery with a major intervening side branch.
Given these findings, it seems that FFR assessed in the
proximal uninvolved branch is reliable in the setting of LM
Figure 4. Effect of LAD Disease Versus LCX Disease on Assessment of LM FFR
(A) Difference between FFRLM apparent and FFRLM true for LAD stenoses. (B)
Difference between FFRLM apparent and FFRLM true for LCX stenoses. Abbrevi-
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1025stenosis. In the setting of severe downstream disease, the
operator needs to be aware that the FFR may be falsely
elevated, and alternative methods for assessing the left main,
such as intravascular ultrasound, can be considered. From a
practical perspective, if the composite FFR with the pres-
sure sensor in the distal LAD in a patient with LM plus
LAD disease is 0.65, our data suggest that assessment of
the LM contribution to ischemia with the pressure sensor in
the proximal LCX is accurate using the usual cutoff of 0.75
to 0.80 for FFR decision making.
Study limitations. Our method was applied to an in vitro
model of the coronary circulation, which though previously
validated, may harbor important differences to human coronary
physiology. Notably, there is no collateral circulation, and that
might affect the accuracy of our equations, although collaterals
would be expected to lessen the impact of downstream disease
on LM FFR. These findings will need to be confirmed in an
in vivo model. We also did not test the impact of lesion
location within the epicardial vessel, because of limitations of
our in vitro model. All lesions in this study were considered
proximal. Theoretically, a distal lesion would have even less
affect on flow across the LM and less tendency to lead to an
overestimation of the FFR. This will need to be confirmed in
an in vivo model. A limitation of our equation for FFRLM
redicted is that it requires knowledge of absolute or relative
ows, which is not currently practical for clinical purposes.
hat being said, the purpose of testing this equation was to
end support to the physiological basis for the observed phe-
omenon and not to propose a clinical method for improving
he interpretation of LM FFR in this setting. In the future,
Figure 5. Results of an Equation To Predict LM FFR in the Setting of
Downstream Stenosis
Plot of FFRLM true minus the predicted true FFR of the LM stenosis in the
setting of concomitant LAD or LCS (FFRLM predicted) on the y-axis as a func-
tion of downstream stenosis severity (composite LM  LAD or LCX FFR) on
the x-axis. Dashed lines represent 95% conﬁdence intervals. For a ﬁxed LM
stenosis, FFRLM predicted accurately estimates FFRLM true through the range
of downstream stenosis severity. Abbreviations as in Figures 1 and 2.implified methods for determining absolute or relative coro-ary flow in vivo might allow the use of our equations for
djudicating LM lesions with even severe downstream disease.
onclusions
In an in vitro model of the coronary circulation, we found that
mild to moderate proximal LAD or LCX disease did not
significantly affect LM FFR when the pressure wire is posi-
tioned in the nondiseased epicardial vessel. In the setting of
severe proximal downstream disease, the LM FFR may be
falsely elevated. Our theoretical model for FFRLM predicted
functioned well to estimate true LM FFR and validates the
theoretical considerations of complex serial lesion assessment.
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APPENDIX
For an explanation of the derivation of FFR in terms of coronary resistance,
please see the online version of this paper.
